文献速递中毒与环境急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性稻丰散自服中毒:一项前瞻性病例系列研究

Acute phenthoate self-poisoning: a prospective case series.
PubMed 文献 · Clin Toxicol (Phila) · 2021-05-07
一句话结论稻丰散自服中毒病死率6.5%,多数呼吸衰竭患者早期插管,死亡多发生在摄入后24小时内插管的患者中。

该研究为斯里兰卡8家医院2002至2018年的前瞻性队列研究,纳入292例稻丰散自服中毒患者,记录临床结局。中位入院时间3.9小时,42例(14.4%)插管,中位插管时间7.2小时,中位插管时长74.8小时;19例死亡,病死率6.5%(95%CI 4.0-10.0),中位死亡时间37小时。81例血样中位血浆稻丰散浓度135 ng/mL;6例接受2 g氯解磷定者中5例胆碱酯酶活性初始升高但未持续。作者认为稻丰散中毒病死率6.5%,多数呼吸衰竭患者早期插管,死亡多发生于摄入后24小时内插管的患者;肟类疗效需进一步研究。

要点

  • 292例稻丰散自服中毒患者中42例(14.4%)接受插管,其中81%(30/37)在摄入后24小时内插管,中位插管时间7.2小时(IQR 2.6-20.9)。
  • 19例死亡,病死率6.5%(95%CI 4.0-10.0),中位死亡时间37小时(IQR 16-101.7);多数死亡发生在摄入后24小时内插管的患者中。
  • 中位插管时长74.8小时(IQR 26.8-232.5),幸存者最长插管592小时。
  • 81例有血样患者中位血浆稻丰散浓度135 ng/mL(IQR 62.7-356.5),即0.42 µmol/mL(0.2-1.1 µmol/mL)。
  • 6例接受2 g氯解磷定者中5例乙酰胆碱酯酶和丁酰胆碱酯酶活性初始升高,但持续输注氯解磷定后未持续。

适用人群与场景

  • 2002至2018年斯里兰卡8家医院就诊的稻丰散自服中毒患者,摄入农业用稻丰散制剂。

处置流程与药物剂量

  • 6例患者接受氯解磷定2 g,其中5例乙酰胆碱酯酶和丁酰胆碱酯酶活性初始升高,但持续输注氯解磷定后未持续。

红旗征与不能漏的情况

  • 呼吸衰竭需插管:42例(14.4%)插管,多数(30/37,81%)在摄入后24小时内插管。
  • 死亡多发生在摄入后24小时内插管的患者中,中位死亡时间37小时(IQR 16-101.7)。

研究设计与关键结果

  • 前瞻性队列研究,纳入292例稻丰散自服中毒患者,中位入院时间3.9小时(IQR 2.4-6.8)。
  • 42例(14.4%)插管,中位插管时间7.2小时(IQR 2.6-20.9),中位插管时长74.8小时(IQR 26.8-232.5),幸存者最长592小时。
  • 19例死亡,病死率6.5%(95%CI 4.0-10.0),中位死亡时间37小时(IQR 16-101.7)。
  • 81例有血样患者中位血浆稻丰散浓度135 ng/mL(IQR 62.7-356.5),即0.42 µmol/mL(0.2-1.1 µmol/mL)。
  • 6例接受氯解磷定2 g者中5例胆碱酯酶活性初始升高但未持续。

证据类型、等级与局限

  • 证据类型:前瞻性病例系列(队列研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为稻丰散自服中毒病死率为6.5%,多数呼吸衰竭患者接受早期插管,死亡多发生在摄入后24小时内插管的患者中。
  • 作者认为氯解磷定后胆碱酯酶活性呈非持续性升高,肟类在稻丰散自服中毒中的临床疗效程度需进一步研究分析。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The clinical characteristics following self-poisoning with organophosphorus (OP) insecticides differs according to the insecticide ingested. Phenthoate is a dimethoxy WHO Hazard Class II OP pesticide with limited literature on its clinical characteristics and outcome. We aimed to better understand its clinical characteristics by studying patients with phenthoate self-poisoning in Sri Lanka.

METHODS: We conducted a prospective cohort study of patients presenting with phenthoate self-poisoning to eight hospitals in Sri Lanka between 2002 and 2018. Clinical outcomes were recorded for each patient. Blood samples for measuring plasma phenthoate concentration, cholinesterase activity, and response to oximes were available for a very small number of patients recruited to a clinical trial.

RESULTS: Two hundred and ninety-two patients who ingested agricultural phenthoate formulations were included in the study. Median time to admission was 3.9 (IQR 2.4 - 6.8) h. Forty-two (14.4%) patients were intubated, mostly (30/37, 81%) within 24 h of ingestion (median time to intubation 7.2 [IQR 2.6-20.9] h). Median duration of intubation was 74.8 (IQR 26.8-232.5) h; the longest duration in a survivor was 592 h. Nineteen died (case fatality 6.5%, 95% CI 4.0-10.0); median time to death was 37 (IQR 16 - 101.7) h. Median plasma phenthoate concentration in patients with samples (n = 81) was 135 (IQR 62.7-356.5) ng/mL (0.42 µmol/mL [0.2 to 1.1 µmol/mL]). Five of six patients receiving pralidoxime chloride 2 g showed an initial increase in AChE and BuChE activity that was not sustained despite an infusion of pralidoxime.

CONCLUSION: Phenthoate self-poisoning has a 6.5% case fatality rate. Most patients who experience respiratory failure undergo early intubation; most deaths occurred among those patients who were intubated less than 24 h after ingestion. There was a non-sustained increase in cholinesterase activity with pralidoxime, but further studies are required to analyse the extent to which oximes are clinically effective in phenthoate self-poisoning.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Rambabu L, Mohamed F, Dhanarisi J, et al. Acute phenthoate self-poisoning: a prospective case series. Clin Toxicol (Phila). 2021. PMID: 33960866. doi:10.1080/15563650.2021.1917596

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。